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CD4+CD25+ regulatory T cells (T reg cells) ex-
pressing the forkhead family transcription factor 
Foxp3 play a nonredundant role in maintaining 
dominant immunological tolerance (Sakaguchi 
et al., 2008). Experimental evidence suggesting 
an important function of the thymus in produc-
ing T reg cells includes the demonstration of the 
presence of Foxp3+ T cells in the thymus by ex-
pression analysis in single cells (Fontenot et al., 
2005b) and the reduction of peripheral T reg 
cell numbers by neonatal thymectomy at day 3 
after birth (Sakaguchi et al., 1985). Besides   
thymic T reg cell generation, initially naive 
CD4+Foxp3 T cells can extrathymically ac-
quire a Foxp3+ T reg cell phenotype in several 
in vitro and in vivo experimental settings, such 
as TGF- treatment in vitro (Chen et al., 2003; 
Fantini et al., 2004, 2007) or homeostatic expan-
sion in lymphopenic mice (Curotto de Lafaille 
et al., 2004; Knoechel et al., 2005). Under more 
physiological conditions, antigen (Ag)-specific 
T reg cells can be induced in vivo from TCR 
transgenic CD4+ T cells by delivering Ag under 
subimmunogenic conditions, such as infusion by   
implanted osmotic minipumps (Apostolou and 
von Boehmer, 2004) or injection of recombi-
nant anti–DEC-205 fusion antibodies to tar-
get steady-state DCs (Kretschmer et al., 2005, 
2006). In contrast to TGF-–mediated in vitro 
generation of Foxp3+ cells (Floess et al., 2007; 
Polansky et al., 2008), DC-targeted T reg cell 
de novo generation in vivo results in efficient 
demethylation of conserved CpG motifs within 
the noncoding part of the Foxp3 gene (Polansky 
et al., 2008), which is a predictive parameter for 
the long-term stability of induced Foxp3 expres-
sion. Consequently, T reg cells generated in this 
manner survive for extended periods of time in 
the absence of the inducing Ag and maintain a 
stable Foxp3+ suppressor phenotype under im-
munogenic conditions (Kretschmer et al., 2005; 
Polansky et al., 2008).
Consistent with the absence of deliberate 
DC  activation  as  a  prerequisite  for  efficient 
DC-targeted T reg cell conversion, cells that 
proliferate  least  induce  Foxp3  expression   
more efficiently than those that divide robustly 
(Kretschmer et al., 2005). The capacity of spe-
cialized subsets of steady-state DCs in lymphoid 
tissues to induce Foxp3 expression is further 
corroborated by the observation that CD103+ 
DCs from the small intestine and intestine- 
associated lymphoid organs induce Foxp3 ex-
pression in vitro in a small fraction of initially 
CD4+Foxp3 T cells via TGF-– and retinoic 
acid–dependent mechanisms (Benson et al., 
2007;  Coombes  et al.,  2007;  von  Boehmer, 
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CD4+CD25+ regulatory T cells (T reg cells) expressing the transcription factor Foxp3 can  
be induced from peripheral T cell receptor (TCR) transgenic CD4+CD25Foxp3 T cells 
stimulated with noninflammatory dendritic cells presenting low amounts of agonist cog­
nate antigen. However, limited evidence exists for extra­thymic T reg cell generation from  
non­TCR transgenic T cells in unmanipulated mice. We compared events early during  
agonist­driven generation of Foxp3+ TCR transgenic T cells to polyclonal CD4+ T cell popu­
lations in unmanipulated mice. We identified an interleukin­2– and phosphatidylinositol­ 
3­kinase–dependent precommitted Foxp3 precursor to Foxp3+ T reg cells in peripheral 
lymphoid organs. Transforming growth factor  signaling played a minor role in the gen­
eration and subsequent differentiation of these T reg precursor cells.
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of TCR-haemagglutinin (HA)107-119 transgenic CD4+ T cells, 
which were purified from donor mice on a recombination-
activating gene (Rag) 2–deficient (Rag2/) background to 
preclude preformed Foxp3+ cells and minute amounts of   
recombinant anti–DEC-205-HA107-119 fusion antibodies to 
target DCs in immunocompetent recipients. To reassess DC 
targeting to de novo generate Foxp3+ T reg cells in vivo, we 
now asked whether this approach can be extended to CD4+ 
T cells from Rag-proficient Foxp3GFP reporter mice with dif-
ferent transgenic TCR specificities. The results show that,   
in  addition  to  TCR-HA107-119  T cell  activation  through   
DC-targeted  HA107-119,  DC-targeted  whole  ovalbumin 
protein  induced  Foxp3GFP  expression  in  H2-IAd–  and   
H2-IAb–restricted DO11.10 and OT2 CD4+ T cells, re-
spectively (Fig. 1 A). In addition, DC targeting of peptide 
mimotopes induced Foxp3 expression in 30–40% of ini-
tially Foxp3 diabetogenic BDC2.5 CD4+ T cells recog-
nizing a NOD I-Ag7–restricted self-Ag in pancreatic  cells 
(unpublished data).
DC-primed congenic marker+ CD4+ T cells were main-
tained in recipient animals for extended periods of time, with 
the exception of OT2 cells which were efficiently deleted by 
day 14 after DC targeting (Fig. 1 B). However, OT2 T cells 
were maintained and readily detectable in isotype control-
treated or untreated recipient mice (Fig. S1, A and B; and not 
depicted). Thus, DC targeting consistently resulted in extra-
thymic induction of Foxp3GFP expression in CD4+ T cells 
with transgenic TCRs to foreign as well as self-Ags, although 
T cell survival and Foxp3 induction efficiency may differ be-
tween individual TCRs.
Tracking TCR transgenic CD4+ T cells in peripheral 
lymphoid organs indicated that 5 d after adoptive transfer 
and DC targeting, congenic marker+ cells preferentially ac-
cumulated in subcutaneous LNs (scLNs; Fig. 1 C), with the 
majority  of  initially  naive  T cells  exhibiting  an  activated 
phenotype, as judged by low CD62L and high CD69 ex-
pression (Fig. 1 D). In addition to high frequencies of cells 
with induced Foxp3GFP expression at this early time point 
during T reg cell conversion, congenic marker+ cells that 
lacked Foxp3GFP but exhibited up-regulated CD25 expres-
sion were most prominent in scLNs (Fig. 1 E). We next 
asked whether these Foxp3 cells that had been activated   
in vivo through DC-targeted Ag may have acquired the   
capacity  to  up-regulate  Foxp3  expression.  To  this  end, 
CD4+Thy1.2+Foxp3GFP  cells  were  FACS  purified  and 
cultured in the presence of IL-2, without deliberate TCR 
or TGF- receptor (TGF-R) stimulation. Flow cytometry 
at different time points after initiation of cultures (Fig. 1 F 
and not depicted) revealed that such CD4+Foxp3 T cells 
rapidly up-regulated Foxp3GFP expression in vitro, with 
CD25+ cells (72.0 ± 5.7%) being more efficient than CD25 
cells (36.5 ± 5.0%; Fig. 1, F and G). We conclude that in 
this in vivo model system of T reg cell conversion, induced 
Foxp3 expression via DC-targeted Ag is preceded by early 
modulation of CD69, CD62L, and CD25 expression in im-
mediate Foxp3 precursor cells.
2007), with retinoic acid interfering with the negative effect of 
high levels of costimulation on T reg cell conversion (Nolting 
et al., 2009). Similar to intestinal DCs, CD8+DEC205+ DCs, 
but not CD8DCIR2+ DCs, from spleen induce functional 
Foxp3+ T reg cells in vitro from yet to be identified CD4+ 
Foxp3 precursor populations in the presence of low Ag doses 
but without exogenous TGF- (Yamazaki et al., 2008).
In non-TCR transgenic animals, infusion of female mice 
with male transplantation antigens resulted in T reg cell– 
mediated long-term tolerance to transplanted male skin (Verginis 
et al., 2008), supporting the notion that de novo generation 
and population expansion of Ag-specific T reg cells may be a 
suitable approach toward immune-based therapies in clinical 
settings of unwanted immunity. However, extrathymic T reg 
cell de novo generation has been documented only for a lim-
ited number of TCR specificities. In addition, it remains 
largely unclear whether molecular and cellular pathways of   
T reg cell generation described in TCR transgenic model 
systems can be extended to non-TCR transgenic T cells under 
physiological conditions. Furthermore, the relative contribu-
tions of thymic and extrathymic differentiation pathways to 
the overall peripheral Foxp3+ T reg cell pool are unknown. 
Approaches, such as TCR-based lineage tracing in BDC2.5 
transgenic mice (Wong et al., 2007) or comparative TCR 
repertoire  analysis  of  T  reg  cells  and  conventional  CD4+ 
T cells (Hsieh et al., 2006; Pacholczyk et al., 2006; Lathrop 
et al., 2008), suggested that peripheral Foxp3+ T reg cells 
may predominantly originate from the thymus. However, 
limitations inherent to the study of T cell repertoires, which 
are likely to be locally shaped by both tissue-specific and for-
eign Ags and lack of suitable surface markers to identify ex-
trathymic T reg precursor cells or to distinguish thymically 
and extrathymically generated Foxp3+ cells, remain substan-
tial experimental obstacles.
In this paper, we report on our attempts to track extra-
thymic generation of polyclonal T reg cells in unmanipulated 
mice. Analysis of early events during agonist ligand DC- 
targeted T reg cell generation from TCR transgenic CD4+ 
T cells allowed us to delineate differentiation stages to extra-
thymic Foxp3+ T reg cells with distinct surface marker ex-
pression. Correlating these findings with polyclonal T cells 
from  WT  mice  helped  identify  a  sizeable  population  of 
CD4+Foxp3 T cells in peripheral lymphoid organs that are 
precommitted to differentiate into Foxp3+ T reg cells. Our 
results indicate that both thymic and extrathymic T reg cell 
generation contributes to the overall Foxp3+ T reg cell pool 
in peripheral lymphoid organs of nonmanipulated mice.
RESULTS
Extrathymic differentiation of Ag­specific Foxp3 
precursors to Foxp3+ T reg cells
Previous studies indicated that low-dose antigenic stimula-
tion by noninflammatory DCs in vivo favors extrathymic 
conversion of naive CD4+ T cells into functional CD25+ 
Foxp3+ T reg cells (Kretschmer et al., 2005). These experi-
ments took advantage of an adoptive transfer model consisting JEM VOL. 207, July 5, 2010 
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Extrathymic differentiation of polyclonal Foxp3 precursors 
to Foxp3+ T reg cells
Having shown that during DC-mediated T reg cell conver-
sion, TCR transgenic CD4+Foxp3 T cells undergo a series 
of differentiation steps that are characterized by differential 
expression of distinct surface markers, we sought to determine 
Figure 1.  Tracking extrathymic differentiation of 
Ag­specific CD4+ T cells during DC­mediated Foxp3 
induction. (A and B) Using clonotypic antibodies (TCR-
HA107-119: 6.5, DO11.10: KJ1-26) or anti–V2/-V5.1/5.2 
antibodies (OT2), naive TCR transgenic T cells (CD4+CD25
CD62L+Foxp3GFP) were FACS purified from Rag-proficient 
Foxp3GFP mice (A, top). 2 × 106 cells were adoptively trans-
ferred i.v. into congenic recipients, which were injected i.p. 
with anti–DEC-205 antibodies fused to respective Ags 
(anti–DEC-205-HA107-119, 50 ng; anti–DEC-205-ovalbumin, 
250 ng) the next day. Flow cytometry of congenic marker+ 
cells (A, middle) for induced Foxp3GFP expression (A, bot-
tom) at day 7 and percentages of congenic marker+ cells  
at day 14 in pools of LNs (B). (C) Numbers of transferred 
Thy1.2+DO11.10+ (left) or Thy1.2+TCR-HA107-119 (right) cells 
recovered from indicated organs at day 5 after injection of 
anti–DEC-205-ovalbumin or anti–DEC-205-HA107-119, re-
spectively. (D–G) Analysis of transferred Thy1.2+DO11.10+ 
cells at day 5 after anti–DEC-205-ovalbumin injection.  
(D) Flow cytometry of scLN-derived Thy1.2+ cells for  
Foxp3GFP, CD62L, and CD69 expression. (E) Percentages of 
CD4+Thy1.2+Foxp3 cells with up-regulated CD25 expres-
sion recovered from indicated organs. Dots and horizontal 
lines in C and E indicate individual mice and mean values, 
respectively. (F) CD25+Foxp3 and CD25Foxp3 subsets 
among Thy1.2+DO11.10+ cells from scLNs of Foxp3GFP mice 
were FACS purified from recipients at day 5 after transfer 
(top). CD25 and Foxp3GFP expression was determined at 
day 3 of IL-2–containing cultures (bottom). (G) Percent-
ages (left) and numbers (right) of Foxp3GFP-expressing cells 
at day 3 of cultures of initially Foxp3DO11.10+ cells, 
which were isolated from spleen or mLNs irrespective of 
their CD25 expression (Foxp3 total), or isolated from 
scLNs based on CD25Foxp3 or CD25+Foxp3 expression. 
Numbers in histograms and dot plots indicate the percent-
age of gated cells in respective quadrants or gates. Dots 
and horizontal lines indicate replicate wells and mean 
values, respectively. Data are representative of at least 
three independent experiments with pooled cells of three 
to six mice.
whether equivalent CD4+Foxp3 precursor pop-
ulations to Foxp3+ T reg cells exist in peripheral 
lymphoid organs of nonmanipulated mice. FACS 
analysis of Foxp3GFP mice showed that substantial 
numbers  of  CD4+CD25+Foxp3  cells  (Fig. 2  A)   
with  differential  CD69  and  CD62L  expression 
(Fig. 2  B)  could  be  detected  in  peripheral  lym-
phoid organs but were near the level of detection 
among peripheral blood mononuclear cells. Next, 
CD4+CD25+Foxp3 cells from spleen, mesenteric 
LNs (mLNs), and scLNs were FACS purified and 
tested for their capacity to differentiate into Foxp3+ 
cells in vitro. These experiments established conditions that 
resulted in sizeable numbers of initially CD4+CD25+Foxp3 
cells with up-regulated Foxp3 protein expression in IL-2– 
supplemented cultures (Fig. 2, C–F), with differentiation   
of precursors to Foxp3+ cells reaching a plateau at 72 h 
(Fig. 2 D). FACS purification of CD4+CD25+Foxp3 cells 1396 Peripheral precursor to Foxp3+ T reg cells | Schallenberg et al.
CD4+Foxp3 cells based on CD25 expression levels estab-
lished that CD25low cells yield substantially fewer Foxp3+ cells 
than CD25high cells, whereas CD25Foxp3 cells did not give 
rise to Foxp3+ cells (Fig. S2 A). Notably, with regard to num-
bers of cells with up-regulated Foxp3GFP expression, peripheral 
CD4+CD25+Foxp3 precursors were consistently superior to 
CD4+CD8CD25+Foxp3 thymic precursors, as total cell 
numbers recovered at day 3 of cultures were four- to fivefold 
higher from cultures with peripheral than with thymic pre-
cursor populations (Fig. S2 A). Foxp3 induction in precursor 
populations from thymus and peripheral lymphoid organs was 
strictly dependent on the presence of exogenous IL-2 (Fig. 2 E   
and Fig. S2 A). The common gamma chain cytokines IL-4, 
IL-7, and IL-15 substantially improved survival of cultured cells 
(not depicted) but did not appreciably induce up-regulation 
of  Foxp3GFP  protein  expression  in 
precursor  populations  from  periph-
eral  lymphoid  organs  (Fig. S2  C). 
Consistent  with  previous  results 
(Lio  and  Hsieh,  2008),  high-dose 
IL-15  had  some  beneficial  ef-
fect  on  thymic  CD4+CD8CD25+ 
Foxp3  precursor  differentiation 
(Fig. S2  C).  Furthermore,  addition 
of LY294002, a potent inhibitor of 
from day-3 cultures revealed no up-regulation of Foxp3GFP 
expression in secondary cultures (unpublished data). In sum-
mary, secondary lymphoid tissues of nonmanipulated mice 
contain CD4+CD25+Foxp3 T reg precursor cells, which are 
reminiscent of a thymic CD4+CD8CD25+Foxp3 T cell 
population (Fig. 2, A–F) which has recently been described 
by Lio and Hsieh (2008) to contain precursors to Foxp3+  
T reg cells.
With some experiments yielding 40–50% of Foxp3+ cells 
at day 3 of culture, CD4+CD25+Foxp3 cells from scLNs 
were  consistently  superior  with  regard  to  up-regulation  of 
Foxp3 expression compared with cells originating from other 
secondary lymphoid organs (Fig. 2 C and see Fig. 7 C). This 
also holds true for numbers of Foxp3+ cells recovered from 
such cultures (Fig. S2 A). Subfractionation of peripheral 
Figure 2.  Tracking extrathymic  
differentiation of polyclonal 
CD4+CD25+Foxp3 T cell precursors to 
Foxp3+ cells in nonmanipulated mice.  
(A) Flow cytometry of CD25 and Foxp3GFP 
expression among gated CD4+ cells of indi-
cated origin before (top) and after (bottom) 
magnetic bead enrichment of CD25+ cells. 
Numbers in dot plots indicate the percent-
age of gated cells within the respective gate. 
(B) Flow cytometry of CD69 and CD62L 
expression among gated CD4+CD25+Foxp3 
cells from anatomical locations as indicated 
in A. (C) CD4+CD25+Foxp3 cells from  
secondary lymphoid organs and 
CD4+CD8TCR+CD25+Foxp3 cells from 
thymus were purified by flow cytometry and 
CD25 and Foxp3GFP expression was assessed 
at day 3 of IL-2–containing cultures  
(n.d., not detectable). (D–F) Analysis of 
CD4+CD25+Foxp3 cells from indicated 
lymphoid organs of Foxp3GFP mice for their 
capacity to up-regulate Foxp3GFP expression 
in the presence of 1,000 U/ml IL-2 at indi-
cated time points of culture (D), in the pres-
ence of indicated amounts of IL-2 at day 3 
of culture (E), and in the presence of  
1,000 U/ml IL-2 and titrating amounts of 
LY294002 (0, 2.5, 10, or 40 µM) at day 3 of 
culture (F). Data are representative of at 
least two independent experiments. Error 
bars indicate SD of triplicate wells.JEM VOL. 207, July 5, 2010 
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(Fig. S2 E), even at high concentrations which in control ex-
periments substantially diminished proliferation of conventional 
CD4+ T cells in response to TCR stimulation (Fig. S3).
In vivo differentiation, stability, and suppressor function
Analysis of LN-derived CD4+CD25+Foxp3 cells at differ-
ent time points after adoptive transfer into congenic fully im-
munocompetent recipients revealed rapid up-regulation of 
Foxp3 protein expression in 20% of initially Foxp3 cells 
(Fig. 3 A). Thus, Foxp3 up-regulation in CD4+CD25+Foxp3 
phosphatidylinositol-3-kinase  activity,  abrogated  peripheral 
CD4+CD25+Foxp3 precursor differentiation to Foxp3+ 
cells in a dose-dependent manner (Fig. 2 F and Fig. S2 D). 
In addition, TCR stimulation (either via plate-bound anti-
CD3 antibodies in the absence or presence of costimulatory 
anti-CD28 antibodies or anti-CD3/CD28–coated beads) ef-
ficiently abrogated in vitro induction of Foxp3 expression in 
peripheral CD4+CD25+Foxp3 precursors (Fig. S2 B and not 
depicted). Finally, the mTOR inhibitor rapamycin did not   
alter  CD4+CD25+Foxp3  precursor  differentiation  in  vitro 
Figure 3.  Characterization of CD4+CD25+Foxp3 precursor and differentiated Foxp3+ T cells. (A) Differentiation of CD4+CD25+Foxp3 precur-
sors to Foxp3+ T cells in vivo. CD4+CD25+Foxp3Thy1.2+ cells were FACS purified from LNs of Foxp3GFP mice. Presort analysis among gated CD4+ cells after 
magnetic bead enrichment of CD25+ cells (top left) and postsort analysis (bottom left) are depicted. FACS-purified cells (4 × 104) were injected i.v. into 
immunocompetent congenic recipients. Thy1.2+ cells were analyzed for CD25 and Foxp3GFP expression at days 3 and 6. Numbers in dot plots indi-
cate percentages of gated cells in the respective quadrant or gate. (B and C) Stability of in vitro–differentiated CD4+CD25+Foxp3+ T cells in vivo. 
CD4+CD25+Foxp3Thy1.2+ cells were cultured in the presence of IL-2. At day 3, total cells (2 × 105) were coinjected i.v. with naive CD62L+CD25Foxp3 
Thy1.1+CD4+ T cells (8 × 106) into Rag2/ mice (B) or total cells (4 × 104) were injected alone into immunocompetent congenic recipients (C). Foxp3GFP 
expression of congenic marker+CD4+ cells in LNs (B and C) and spleen (C) of recipients was tracked at indicated time points. (D) Suppressor function in 
vitro. CFSE-labeled CD4+CD25 T responder (Tresp) cells were cultured with irradiated splenocytes and anti-CD3 antibodies, either alone or co-cultured 
with CD25+Foxp3+ T cells originating from CD4+CD25+Foxp3 precursor cells (Foxp3→Foxp3+) or freshly isolated CD4+CD25+Foxp3+ T reg cells (Foxp3+). 
Median fluorescence intensity (MFI) of CD25 staining (left) and CFSE dilution (right) of T responder cells was determined at day 3. Division cycles of  
T responder cells are indicated by arrowheads. Colors of bars mirror those of histograms. (E) Suppressor function in vivo. Naive CD62L+CD25Foxp3 
Thy1.1+CD4+ T cells (5 × 106) were injected into Rag2/ mice alone or together with 105 total cells from IL-2–containing differentiation cultures of 
Foxp3 precursors as shown in B (bottom left). Data are representative of at least two independent experiments including three to four mice. Dots repre-
sent individual mice, and horizontal bars indicate mean values.1398 Peripheral precursor to Foxp3+ T reg cells | Schallenberg et al.
marker–mismatched conventional CD4+ T cells as feeder cells 
to provide cytokines such as IL-2. Kinetic studies demonstrated 
that  a  sizeable  population  of  CD25+Foxp3+  T cells,  which 
originated  from  in  vitro–differentiated  CD4+CD25+Foxp3 
precursors, was maintained in recipients for at least 19 d after 
transfer (Fig. 3 B). Adoptive transfers using day-3 cultures of 
peripheral CD4+CD25+Foxp3 precursors and fully immuno-
competent congenic recipients further corroborated the in vivo 
stability of Foxp3+ cells (Fig. 3 C).
The capacity of de novo–generated CD4+CD25+Foxp3+ 
T cells to suppress conventional CD4+ T cells in standard co-
culture assays was indistinguishable from that of freshly isolated 
LN-derived CD25+Foxp3+ T reg cells, as judged by abroga-
tion of both proliferation and expression of the early activation 
cells can be achieved in vivo to an extent that is comparable 
to what we observed in IL-2–containing cultures. In addi-
tion, adoptive transfer of CD4+CD25+Foxp3 populations 
into Rag2/ mice, which promotes T cell homeostatic pro-
liferation in a cytokine-deprived environment, did not lead 
to up-regulation of Foxp3 expression (not depicted), which 
is  consistent  with  strict  requirements  for  IL-2  receptor   
(IL-2R) signaling (Fig. 2 E and Fig. S2 A) and limited TCR 
stimulation in vitro (Fig. S2 B).
Next, we asked whether differentiation of CD4+CD25+ 
Foxp3 cells gives rise to stable and functional CD25+Foxp3+ 
T reg cells. To this end, CD4+CD25+Foxp3 populations were 
cultured in the presence of IL-2 (Fig. 3 B, left), and day-3 cul-
tures were injected into Rag2/ mice, together with congenic 
Figure 4.  Differentiation capacities of CD4+CD25+Foxp3 precursor subsets. (A and B) Total CD4+CD25+Foxp3 populations (A) or CD62LCD69, 
CD62LintCD69+ and CD62L+CD69 subsets (B) among gated CD4+CD25+Foxp3 cells were FACS purified from indicated lymphoid organs of Foxp3GFP mice, 
cultured in the presence of IL-2, and analyzed by flow cytometry for up-regulated Foxp3GFP expression at day 3 of cultures. Numbers in dot plots and histo-
grams indicate the percentage of gated cells in the respective quadrant or gate. (C) Percentages (left) and absolute numbers (right) of Foxp3GFP+ cells  
originating from total populations of initially CD4+CD25+Foxp3 cells or populations that were subfractionated based on differential CD62L and CD69 ex-
pression, as indicated. Error bars indicate SD of triplicate wells. (D) Pacific Blue–succinimidyl ester (Pacific Blue–SE)–labeled CD4+CD25+Foxp3 cells from 
scLNs or thymus of Foxp3GFP mice were cultured in the presence of IL-2 and were analyzed by flow cytometry at day 3 for up-regulated Foxp3GFP expression 
and cell division, as revealed by dilution of Pacific Blue–succinimidyl ester. Division cycles are indicated by arrowheads. Numbers in dot plots indicate the 
percentages of undivided and divided cells among Foxp3+ cells. (E) Flow cytometry of CD62L and CD69 expression among gated CD25+Foxp3 and 
CD25+Foxp3+ cells at day 3 of IL-2–containing cultures of CD4+CD25+Foxp3 precursor cells from thymus or LNs of Foxp3GFP mice. See Fig. 2 for compari-
son with CD4+CD25+Foxp3 precursor cells before in vitro differentiation. Data are representative of at least two independent experiments.JEM VOL. 207, July 5, 2010 
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the CD62LintCD69+ subpopulation (Fig. 4, B and C). This be-
came most obvious when the in vitro conversion efficiency of 
the total CD4+CD25+Foxp3 population from spleen (Fig. 4 A, 
3.6%) was compared with the respective CD62LintCD69+ sub-
population (Fig. 4 B, 26.2%). Overall, the CD62L+CD69 and 
CD62LCD69– subpopulations exhibited modest to no capac-
ity to up-regulate Foxp3 expression (Fig. 4, B and C). Con-
sistently, comparative gene expression analysis of CD4+ 
CD25+Foxp3  subsets  revealed  low  but  significant  Foxp3 
mRNA  expression  in  the  CD62LintCD69+  subpopulation, 
whereas expression levels of RORt, T-bet, GATA-3, and   
T reg cell signature genes were negligible (Fig. 5, A and B). 
Furthermore, CD4+CD25+ T cells with in vitro up-regulated 
Foxp3GFP protein expression exhibited mRNA expression   
of so-called T reg signature genes such as CD103, CTLA-4, 
Gpr83, and Helios (Fig. 5 B and not depicted).
Importantly, >50% of Foxp3+ cells originating from 
thymic  and  peripheral  CD62LintCD69+  precursor  cells 
remained undivided in vitro (Fig. 4 D), suggesting that dif-
ferences among subpopulations in their ability to up-regulate 
Foxp3  expression  were  not  a  result  of  differences  in  their 
proliferative capacity. It is of note that thymic and peripheral   
CD4+CD25+CD62LintCD69+Foxp3 precursors up-regulated 
CD62L expression to high levels during induction of Foxp3 
protein expression (Fig. 2 B and Fig. 4 E).
Contribution of the thymus to the pool of peripheral 
Foxp3 T reg precursor cells
We  reasoned  that  extrapolating  numbers  of  in  vitro– 
generated Foxp3+ cells to culture input and CD4+CD25+Foxp3 
marker CD25 on T responder cells (Fig. 3 D). Next, we wanted 
to  assess  the  in  vivo  immunoregulatory  capacity  of  Foxp3+  
T reg cells originating from CD4+CD25+Foxp3 precursors. 
We therefore analyzed homeostatic expansion and accumulation 
of conventional CD4+ T cells that had been adoptively trans-
ferred into Rag2/ mice either alone or together with congenic 
marker–mismatched Foxp3+ T reg cells from peripheral precur-
sors at day 3 of IL-2–containing cultures. The results show that 
such Foxp3+ T reg cells efficiently suppressed accumulation of 
conventional CD4+ T cells in lymphopenic hosts (Fig. 3 E).
The CD4+CD25+CD62LintCD69+ subset is enriched  
for Foxp3 T reg precursor cells
Compared with spleen or mLNs, IL-2–mediated in vitro dif-
ferentiation  of  equivalent  input  numbers  of  scLN-derived 
CD4+CD25+Foxp3 cells consistently yielded substantially 
more CD25+Foxp3+ cells (Fig. 2 C, Fig. S2 A, and Fig. 4 A), 
suggesting that differences in frequencies of precommitted ex-
trathymic T reg precursor cells in the respective microenviron-
ments may exist. In fact, CD4+CD25+Foxp3 cells can be 
subdivided  into  distinct  CD62L+CD69,  CD62LintCD69+, 
and CD62LCD69 subpopulations that are differently distrib-
uted  between  peripheral  lymphoid  organs  (Fig. 2  B),  with 
CD62LCD69 and CD62LintCD69+ cells being most promi-
nent in spleen and LNs, respectively. When we FACS purified 
individual CD4+CD25+Foxp3 subpopulations from the dif-
ferent peripheral lymphoid organs of Foxp3GFP mice (Fig. 4 B, 
top) and analyzed their capacity to undergo IL-2–mediated dif-
ferentiation into Foxp3+ cells in vitro, it became clear that pre-
committed extrathymic T reg precursor cells were enriched in 
Figure 5.  mRNA expression in CD4+CD25+Foxp3 precursor subsets and differentiated CD25+Foxp3+ T reg cells. Expression of mRNA encoding 
indicated T cell lineage transcription factors (A) and selected T reg cell signature genes (B) was determined by real-time RT-PCR in freshly isolated 
CD4+CD25+Foxp3 precursor subsets presented in Fig. 4 B. Freshly isolated scLN-derived CD4+CD25+Foxp3+ cells and conventional CD4+ T cells that had 
been cultured under Th1-, Th2-, or Th17-polarizing conditions were included as positive controls as indicated. CD25+Foxp3+ T cells that were in vitro dif-
ferentiated from CD4+CD25+Foxp3 precursor cells (Foxp3→Foxp3+) and purified by flow cytometry at day 3 of culture based on Foxp3GFP expression 
are also included. -Actin was used for normalization. Shown are mean and range of duplicate samples. Data are representative of at least two indepen-
dent experiments.1400 Peripheral precursor to Foxp3+ T reg cells | Schallenberg et al.
efficiency of T reg cell generation from peripheral 
and  thymic  CD4+CD25+Foxp3  precursors  con-
tinuously decreased with progressive thymic involu-
tion during aging of mice. To address the possibility 
that maintenance of the peripheral T reg precursor 
cell population throughout life may directly depend 
on the influx of newly produced T cells from the 
thymus, we next aimed at assessing the contribution 
of recent thymic emigrants (RTEs) to the periph-
eral pool of Foxp3 precursor cells. For this, we 
took advantage of mice carrying a GFP transgene 
driven by the Rag2 promoter (hereafter referred to 
as RAG2p-GFP mice; Yu et al., 1999). In these 
mice, high levels of GFP expression mark RTEs in periph-
eral lymphoid organs within 1 wk after the cells left the thy-
mus (Boursalian et al., 2004). CD4+CD25+ T cells from LNs 
were isolated by flow cytometry to high purity based on ab-
sence or presence of RAG2p-GFP expression (Fig. 6 B) and 
subsequently subjected to intracellular staining using fluoro-
chrome-conjugated mAbs to Foxp3. This two-step approach 
ensured  faithful  identification  of  RAG2p-GFPhigh  RTEs 
among CD4+CD25+Foxp3 precursors because the RAG2p-
GFP fluorescence was found to be severely abrogated by the 
fixation/permeabilization procedure (unpublished data). The 
results indicated equivalent frequencies of CD62L+CD69, 
CD62LintCD69+,  and  CD62LCD69  cells  among  the 
precursor cell numbers in vivo may provide an approxima-
tion of Foxp3+ T reg cell numbers produced in vivo. Thus, 
in an attempt to compare the capacity of thymus and pe-
ripheral lymphoid organs to produce Foxp3+ T reg cells, 
CD4+CD25+Foxp3 precursors were FACS purified from 
thymus, spleen, mLNs, and pools of different scLNs (for de-
tails see Materials and methods) of individual Foxp3GFP mice. 
Equivalent T cell numbers were seeded in the presence of 
IL-2 and output of Foxp3+ cell numbers was determined at 
day 3 of cultures. The results indicated that the thymus of 
young mice appeared more efficient in producing Foxp3+ 
cells compared with the restricted set of peripheral lymphoid 
tissues included in these experiments (Fig. 6 A). Overall, the 
Figure 6.  Contribution of the thymus to the peripheral 
pool of CD4+CD25+Foxp3 T reg precursor cells. (A) Ap-
proximation of Foxp3+ T reg cell numbers produced in periph-
eral lymphoid organs and thymus. For this, total numbers of 
CD4+CD25+Foxp3 cells in peripheral lymphoid organs (spleen, 
mLNs, and a set of scLNs; see Materials and methods) or thy-
mus of individual Foxp3GFP mice were determined. Equivalent 
numbers of FACS-purified peripheral and thymic precursor 
populations were cultured in the presence of IL-2, and abso-
lute numbers of Foxp3+ cells were determined at day 3 of cul-
ture. Estimated contribution of precursor populations to the 
peripheral T reg cell pool was calculated as follows: [total 
numbers CD4+CD25+Foxp3 cells ex vivo] × [absolute numbers 
Foxp3+ cells in vitro] ÷ [absolute numbers CD25+Foxp3 cells 
culture input]. Each dot represents an individual mouse of 
indicated age, and horizontal bars indicate mean values.  
(B–D) Contribution of RTEs to the peripheral pool of Foxp3 
precursor cells. (B) Left histogram is gated on CD4+CD25+ 
T cells from LNs of 7-wk-old RAG2p-GFP mice (red filled histo-
grams). Blue histogram depicts CD4+CD8 thymocytes. Right 
histograms show postsort isolation of GFP and GFP+ subsets. 
Numbers in histograms show the percentages of GFPhigh cells 
within the indicated gate. (C) Foxp3 expression, as revealed by 
intracellular staining using the mAb FJK-16s, in FACS-purified 
peripheral CD4+CD25+ T cells that were RAG2p-GFP or 
RAG2p-GFPhigh, and CD62L and CD69 expression among gated 
CD4+CD25+Foxp3 (middle) and CD4+CD25+Foxp3+ T cells 
(bottom). (D) Percentages of RAG2p-GFPhigh cells among indi-
cated thymic and peripheral populations from RAG2p-GFP 
mice at indicated ages. Data are representative of at least two 
independent experiments.JEM VOL. 207, July 5, 2010 
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TGF-R signaling abrogation resulted in an approximately 
twofold  increase  in  CD4+CD25+Foxp3  cell  numbers   
(Fig. 8  C).  Similar  results  were  obtained  with  thymic 
CD4+CD8CD25+Foxp3 T reg precursor cells (Fig. S4 C). 
Furthermore, increasing amounts of exogenous TGF- to 
enhance TGF-R signaling did not help IL-2–mediated up-
regulation  of  Foxp3  expression  in  thymic  or  peripheral   
CD4+CD25+Foxp3CD62LintCD69+  precursor  cultures 
(Fig. 8 D). In addition, analysis of polyclonal populations of 
initially naive CD4+CD62L+CD25Foxp3 T cells from 
dnTGF-RII+ or WT Foxp3GFP mice that had been injected 
as individual populations into congenic recipients revealed 
similar efficiencies of up-regulated Foxp3 expression at day 7 
after adoptive transfer (Fig. S4 D). Lastly, progression of   
either CD25Foxp3 or CD25+Foxp3 TCR transgenic 
CD4+ T cells, which had been primed in vivo through DC-
targeted Ag, to Foxp3+ cells in vitro remained largely unaf-
fected by SB431542-mediated TGF-R signaling abrogation 
(Fig. 8, E and F). However, abrogation of TGF-R signaling 
during CD4+Foxp3 Ag-specific precursor differentiation to 
Foxp3+ cells in vitro resulted in a dose-dependent reduction 
of Foxp3 protein expression levels (Fig. 8 G).
Multiple lines of evidence suggest reciprocal developmental 
pathways for Th17 and T reg cell generation. Although TGF- 
alone promotes both RORt and Foxp3 expression, IL-6 in 
concert with inflammatory cytokines is thought to have a pivotal 
function in promoting Th17 but inhibiting T reg cell generation 
(Bettelli et al., 2006; Ichiyama et al., 2008; Korn et al., 2008; 
Manel et al., 2008; Zhang et al., 2008; Zhou et al., 2008). There-
fore, we asked whether abrogation of IL-6 levels enhances   
anti–DEC-205–mediated extrathymic T reg cell generation in 
vivo. The results indicated that DC-targeted T reg cell conver-
sion of adoptively transferred TCR transgenic CD4+ T cells is 
not enhanced in IL-6 gene-targeted recipients or upon treat-
ment of IL-6–proficient recipients with neutralizing anti–IL-6 
mAbs (unpublished data). To address the possible involvement 
of IL-6 in extrathymic T reg cell conversion in nonmanipulated 
mice,  we  next  analyzed  CD4+CD25+Foxp3  precursor 
populations in polyclonal Foxp3GFP mice that were either 
IL-6 proficient or deficient. This comparative analysis of   
IL-6/ and IL-6+/ mice revealed no significant differences 
with regard to precursor numbers at different anatomical loca-
tions (Fig. S5 A and not depicted) or their capacity to up- 
regulate  Foxp3GFP  expression  in  IL-2–supplemented  cultures 
(Fig. S5 B). Consistently, CD4+CD25+Foxp3 T reg pre-
cursor cells efficiently induced Foxp3 expression in cultures 
supplemented with high dose IL-6 (Fig. S5 C). We conclude 
that accumulation of CD4+CD25+Foxp3 T reg precursor cells 
and their differentiation into Foxp3+ T reg cells in the steady 
state is independent of IL-6.
DISCUSSION
TCR transgenic model systems have been invaluable for the 
elucidation of basic mechanisms of agonist ligand-mediated 
extrathymic T reg cell generation (Apostolou et al., 2002; 
Apostolou and von Boehmer, 2004; Kretschmer et al., 2005). 
CD4+CD25+Foxp3RAG2p-GFP  population  (Fig. 6  C, 
left).  In  contrast,  70%  of  CD4+CD25+Foxp3RAG2p-
GFPhigh cells were comprised of the CD62LintCD69+ sub-
set of peripheral Foxp3 precursor cells (Fig. 6 C, right). 
Notably, this enrichment of peripheral T reg precursor cells 
among RTEs was maintained during aging of mice, whereas 
the  contribution  of  the  total  population  of  peripheral 
CD4+CD25+Foxp3 T cells to the RTE pool decreased in 
the same mice, as expected (Fig. 6 D). These data indicate 
that de novo production of CD4+ T cells from the thymus 
substantially contributes to the maintenance of the peripheral 
T reg precursor cell population.
Function of TGF­ in extrathymic T reg cell conversion  
in the steady state
Numerous studies have shown that in vitro activation in the 
presence of exogenous TGF- induces Foxp3 expression in 
peripheral CD4+CD25 T cells (Fantini et al., 2007). How-
ever, intrathymic T reg cell generation can proceed by TGF-
–independent mechanisms in the absence of TGF- (Marie 
et al., 2005), in the presence of a dominant-negative TGF 
(dnTGF)–RII (Gorelik and Flavell, 2000) or T cell–specific 
deletion of TGF-RII (Li et al., 2006; Marie et al., 2006). 
To address the role of TGF- in extrathymic T reg cell de 
novo generation under steady-state conditions, we character-
ized CD4+CD25+Foxp3 precursor populations in Foxp3GFP 
mice expressing a dnTGF-RII transgene in T cells (Li et al., 
2006). Comparative analysis of TGF-R signaling-proficient 
and -deficient animals revealed no gross differences with re-
gard to proportions and numbers of the CD62LintCD69+ 
subset among CD4+CD25+Foxp3 cells (Fig. 7, A and B). 
Compared with TGF-R signaling-proficient T reg precur-
sor cells, IL-2–dependent in vitro differentiation of FACS-
purified  peripheral  CD4+CD25+Foxp3  cells  indicated  an 
approximately  twofold  reduction  in  the  percentage  of 
CD25+Foxp3+  cells  originating  from  the  CD62LintCD69+ 
subset of dnTGF-RII+ mice, whereas the CD25+Foxp3 
population increased in these cultures (Fig. 7, C and D). It is 
of  note  that  the  numbers  of  Foxp3+  cells  derived  from 
CD62LintCD69+ cells that are either TGF-R signaling 
proficient or deficient were comparable (Fig. 7 D, bottom). 
Similar results were obtained in experiments concerned   
with  IL-2–dependent  in  vitro  differentiation  of  thymic 
CD4+CD8CD25+Foxp3 T reg precursor cells (Fig. S4 A). 
These data suggest that TGF-R signaling plays a minor role 
in both generation and differentiation progression of extra-
thymic CD4+CD25+Foxp3 T reg precursor cells, whereas 
population expansion and/or survival of CD4+CD25+Foxp3 
cells is enhanced. This interpretation is corroborated by the 
observation  that  SB431542,  a  potent  TGF-R  signaling   
antagonist  which  efficiently  abrogated  TGF-R–mediated 
up-regulation of Foxp3 expression in TCR-stimulated conven-
tional CD4+ T cells in vitro (Fig. S4 B), has little if any im-
pact on induction of Foxp3 expression in TGF-R signaling- 
proficient extrathymic CD4+CD25+Foxp3 T reg precursor   
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of whether extrathymic T reg cell generation occurs in the 
steady state, a better understanding of the exact mechanisms of 
non-TCR transgenic T cell conversion has been hampered 
by the lack of suitable markers to identify extrathymic T reg 
Tetramer visualization of Ag-specific CD4+ T cells revealed 
that agonist ligand administration to WT mice can result in   
T reg cell induction from a polyclonal T cell repertoire 
(Verginis et al., 2008). However, in addition to the question 
Figure 7.  Characterization of extrathymic T reg cell differentiation in mice with abrogated TGF­R signaling. (A) Representative flow cytom-
etry of CD69 and CD62L expression among gated CD4+CD25+Foxp3 cells from scLNs of 2-wk-old dnTGF-RII and WT age-matched littermate control 
Foxp3GFP mice. Numbers in dot plots indicate the percentage of gated cells in the respective quadrant or gate. (B) Absolute numbers of CD4+CD25+Foxp3 
cells and indicated subsets among gated CD4+CD25+Foxp3 cells presented in A. Each dot represents an individual mouse. (C) Differentiation of 
CD25+Foxp3+ cells from FACS-purified total CD4+CD25+Foxp3 populations or indicated subsets among CD4+CD25+Foxp3 cells from scLNs of WT con-
trol (top) and dnTGF-RII (bottom) Foxp3GFP mice at day 3 of IL-2–containing cultures. (D) Percentages and absolute numbers of CD25+Foxp3+ and 
CD25+Foxp3 cells originating from WT and dnTGF-RII mice presented in C. Data are representative of two independent experiments with three mice 
per group. Each dot represents an individual triplicate well per condition, and horizontal bars indicate mean values.JEM VOL. 207, July 5, 2010 
Article
1403
Figure 8.  Impact of TGF­R signaling deprivation or enhancement on extrathymic T reg precursor cell differentiation in vitro.  
(A–C) CD4+CD25+ CD62LintCD69+Foxp3 cells were FACS purified from pools of spleen, mLNs, and scLNs of Foxp3GFP mice and cultured with IL-2 in the 
absence or presence of titrating amounts (2.5, 10, and 40 µM) of the Smad kinase inhibitor SB431542. (A) Representative flow cytometry of CD25 and 
Foxp3GFP expression at day 3 of cultures. Numbers in dot plots indicate the percentage of gated cells in the respective quadrant. (B and C) Percentages 
(top) and absolute numbers (bottom) of CD25+Foxp3+ (B) and CD25+Foxp3 (C) cells recovered from these cultures. Dots and horizontal lines indicate 
individual replicate wells and mean values, respectively. Efficient abrogation of TGF-–mediated Foxp3 induction in TCR-stimulated conventional naive 
CD4+ T cells by SB431542 is shown in Fig. S4 B. (D) FACS-purified CD4+CD25+Foxp3 cells from scLNs and CD4+CD8TCR-+CD25+Foxp3 cells from thy-
mus of Foxp3GFP mice were cultured with IL-2 in the presence of titrating amounts of human TGF-1, as indicated. At day 3 of cultures, the impact of 
TGF- was calculated as fold difference of numbers of Foxp3+ cells as follows: [absolute numbers Foxp3+ cells from cultures with added TGF-] ÷ [abso-
lute numbers Foxp3+ cells from cultures without added TGF-]. (E–G) CD25Foxp3 and CD25+Foxp3 cells among Thy1.2+DO11.10+ T cells were FACS 
purified at day 5 after adoptive transfer into congenic recipients and subsequent anti–DEC-205-ovalbumin injection. IL-2–containing cultures with indi-
cated amounts of SB431542 were analyzed at day 3 for CD25 and Foxp3GFP expression. (E) Representative flow cytometric analysis. (F) Percentages (top) 
and absolute numbers (bottom) of CD25+Foxp3 (left) and CD25+Foxp3+ (right) cells recovered from these cultures. (G) Median fluorescence intensities 
(MFI) of Foxp3GFP expression. Shown are the mean and SD of triplicate wells. Data are representative of at least two independent experiments.1404 Peripheral precursor to Foxp3+ T reg cells | Schallenberg et al.
ration  using  aforementioned  RAG2p-GFP  mice  to  track 
RTEs (Boursalian et al., 2004). The results showed that the 
vast majority of OT2 cells (> 80%) in peripheral lymphoid 
organs of adult mice exhibited an immature phenotype, as 
indicated by high GFP expression levels. In contrast, the pe-
ripheral CD4+ T cell pool in TCR-HA107-119 transgenic and 
non-TCR transgenic mice comprised 20–30% RTEs (un-
published observation). Thus, it appears that transgenic TCR 
expression in OT2 cells resulted in aberrant T cell matura-
tion, which might be the underlying cause of enhanced DC 
targeting-induced apoptosis.
Our results indicated that thymic and extrathymic T reg 
cell generation pathways may be more similar than previously 
recognized. In fact, the CD4+CD25+Foxp3 surface marker 
phenotype  of  peripheral  T  reg  precursor  cell  populations   
presented  in  this  study  is  equivalent  to  that  of  CD4+ 
CD8CD25+Foxp3 thymocytes, which have recently been 
suggested to represent T reg precursor cells (Lio and Hsieh, 
2008). It is important to note that previous studies have indi-
cated that Foxp3+ T reg cell lineage commitment can also   
occur at the double-positive (DP) stage of thymic develop-
ment and that Foxp3+CD4+CD8+ DP thymocytes represent 
precursor cells to Foxp3+ T reg cells (Fontenot et al., 2005a,b; 
Wan and Flavell, 2005; Liston et al., 2008). This view has re-
cently been challenged by the notion that numbers of Foxp3+ 
cells in the DP stage may have been overestimated in previous 
studies as a result of a propensity of Foxp3CD4+CD8+ DP 
cells to form doublets with Foxp3+CD4+ single-positive cells 
(Lee and Hsieh, 2009), which is consistent with our own un-
published observation. Lee and Hsieh (2009) further demon-
strated that faithful flow cytometric isolation of Foxp3+ 
CD4+CD8+ thymocytes from Foxp3GFP mice is hampered 
by exceedingly low numbers of DP thymocytes that are 
truly Foxp3+.
We  thus  restricted  our  attempts  to  quantify  thymic   
and extrathymic T reg cell generation to the CD4+CD8 
CD25+Foxp3 precursor populations. The results provided 
evidence that both thymic and peripheral T reg cell develop-
mental pathways may substantially contribute to the overall 
peripheral T reg cell pool in young mice. However, it is im-
portant to note that the calculation is based on controlled in 
vitro conditions in IL-2–complemented cultures, whereas at 
this stage we can only speculate that the availability of cyto-
kines promoting the induction of Foxp3 expression in vivo is 
comparable in thymus and peripheral lymphoid organs. Thus, 
additional experiments that may involve (surface) markers dif-
ferentially expressed on the products of thymic and peripheral 
T reg precursor cells are required to more directly assess the 
relative contribution of thymic and peripheral T reg precursor 
cells to the overall T reg cell pool in the periphery.
Previous studies established that T cell numbers produced 
in the thymus reach a peak at 6 wk of age and continuously 
decrease thereafter (Boursalian et al., 2004). Consistently, our 
comparative analysis of young and adult mice suggested 
that production of CD25+Foxp3+ T reg cells from thymic 
precursors  dropped  early  during  age-associated  thymic   
precursor cell populations and their products in peripheral 
lymphoid  organs.  Consequently,  relative  contributions  of 
thymic and extrathymic T reg cell generation to the overall 
peripheral T reg cell pool under physiological conditions re-
mained unknown.
In this study, we have analyzed activation marker expres-
sion and differentiation capacity of Ag-primed CD4+Foxp3– 
T cells  during  extrathymic  Foxp3  induction  and  have  then 
correlated our findings with polyclonal T cells from nonma-
nipulated  Foxp3GFP  mice.  These  experiments  provided   
evidence for the existence of a sizable population of pre-
committed CD4+Foxp3 precursors to Foxp3+ T reg cells in 
the periphery of steady-state mice. We demonstrated that these 
precursors up-regulated Foxp3 expression and acquired a T reg 
cell phenotype in vivo in adoptive transfer settings, as well as in 
cultures without deliberate TCR and TGF-R stimulation. 
Foxp3 up-regulation was strictly dependent on IL-2R and 
phosphatidylinositol-3-kinase signaling pathways. Foxp3+ T reg 
cells that originated from peripheral Foxp3– precursors exhib-
ited potent in vitro and in vivo suppressive capacity and were 
maintained for extended periods of time in both lymphopenic 
Rag/ mice and normal lympho-replete recipient mice.
We have further shown that the CD62LintCD69+ subset 
among CD4+CD25+Foxp3 T cells in spleen and LNs was 
highly enriched for precursor cells to Foxp3+ T reg cells. Our 
comparative analysis of intermediate Foxp3 precursor popu-
lations from polyclonal nonmanipulated mice and TCR 
transgenic T cells during DC-targeted T reg cell conversion 
revealed striking similarities with regard to activation marker 
phenotype and requirements to up-regulate Foxp3 expres-
sion. In addition, the CD62LintCD69+ subset among CD4+ 
CD25+Foxp3 T cells appeared to be underrepresented in 
blood mononuclear cells compared with peripheral lymphoid 
tissues. This observation, together with the notion that splenic 
CD8+DEC-205+ DCs induce Foxp3 expression in vitro in 
initially CD4+Foxp3– T cells without added TGF- (Yamazaki 
et al., 2008), suggests that steady-state generation of CD4+ 
CD25+Foxp3 T reg precursor cells is likely to be mediated 
by lymphoid tissue–residing CD8+DEC-205+ DCs. At pres-
ent, we can only speculate on the nature of involved antigens, 
but because the peripheral CD4+CD25+Foxp3 T reg pre-
cursor cell compartment appeared fully established in mice as 
early as 2 wk after birth (Fig. 6 A), it is reasonable to hypothe-
size that self-antigens play a prominent role in this process.   
In addition, our experiments on DC-targeted T reg cell 
conversion  of  TCR  transgenic  CD4+  T cells  indicated 
that both foreign and self-antigens can efficiently induce 
Foxp3 expression.
Reminiscent of hen egg lysozyme-specific 3A9 CD4+ 
T cells (Hawiger et al., 2001), anti–DEC-205–mediated DC 
targeting resulted in nearly complete deletion of adoptively 
transferred TCR transgenic OT2 cells. This was in striking 
contrast to what we observed for DO11.10 cells recognizing 
the same ovalbumin peptide. In an attempt to address this   
issue, we have performed initial experiments on the role of 
transgenic TCR expression in peripheral CD4+ T cell matu-JEM VOL. 207, July 5, 2010 
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ripheral Foxp3 T reg precursor cells or differentiated Foxp3+ 
T reg cells from both TCR transgenic or polyclonal CD4+ 
T cells. Although these data clearly indicate that IL-6 may have 
limited impact on peripheral T reg cell generation in the steady 
state, further studies are required to address a possible role of 
IL-6 in T reg cell conversion during inflammation.
In summary, our data have provided evidence for the ex-
istence of an extrathymic CD4+CD25+Foxp3 immediate 
precursor population to Foxp3+ T reg cells in peripheral lym-
phoid organs of nonmanipulated mice that is likely to play   
an important role in maintaining immune homeostasis under 
physiological conditions. A detailed molecular and functional 
analysis of thymic and peripheral precursor populations and 
their products should provide useful insights into intra- and 
extrathymic pathways of dominant tolerance.
MATERIALS AND METHODS
Mice. Thy-1.2 BALB/c and CD45.2 C57BL/6 mice were purchased from 
Janvier or Taconic. Congenic Thy1.1 BALB/c and CD45.1 C57BL/6 mice, 
as well as BALB/c Rag2/ and TCR-HA(107–119) mice, were kindly pro-
vided by H. von Boehmer (Dana-Farber Cancer Institute, Boston, MA). 
TCR-HA107-119, DO11.10 (recognizing the ovalbumin peptide 323–339; 
Ova323-339),  and  dnTGF-RII  (Gorelik  and  Flavell,  2000)  mice  were   
backcrossed to Foxp3IRES-GFP BALB/c mice (Haribhai et al., 2007). RAG2p-
GFP mice (Yu et al., 1999) were backcrossed to BALB/c mice. IL-6-defi-
cient and OT2 (recognizing Ova323-339) mice (The Jackson Laboratory) were 
backcrossed to Foxp3GFP C57BL/6 mice (Fontenot et al., 2005b). The mice 
described in this section were bred and maintained at the Experimental   
Center of the Medizinisch-Theoretisches Zentrum (Dresden University of 
Technology, Germany) or at the animal facility of Max Planck Institute of 
Molecular Cell Biology and Genetics (Dresden, Germany) under specific 
pathogen-free conditions. Animal experiments were performed as approved 
by the Regieriungspräsidium Dresden.
Flow  cytometry  and  cell  sorting. Single cell suspensions of thymus, 
spleen, mLNs (Lnn. mesenterici) and scLNs (Lnn. mandibularis, Lnn. cervicales 
superficiales, Lnn. axillares et cubiti, Lnn. inguinales superficiales, and Lnn. subili-
aci) were prepared using 70-µm cell strainers (BD). mAbs to CD4 (GK1.5 or 
RM4-5),  CD25  (PC61),  CD62L  (MEL-14),  CD69  (H1.2F3),  TCR- 
(H57-597), DO11.10 (KJ1-26), V2 (B20.1), V5.1, 5.2 (MR9-4), CD8 
(53–6.7), Thy 1.2 (53–2.1), and CD45.1 (A20), as well as Fc receptor–blocking   
mAb against CD16/32 (93) and Pacific blue– or PE-conjugated streptavi-
din, were purchased from eBioscience or BD. The mAb to TCR-HA107-119 
(6.5) was purified and conjugated with Alexa Fluor 647 (Invitrogen) in our 
laboratory according to standard protocols. Where indicated, intracellular 
Foxp3 expression was analyzed using the mAb Foxp3 (FJK 16s) and the 
Foxp3 staining buffer set (both eBioscience) according to the manufacturer’s 
protocol. Before FACS, for some experiments CD4+ or CD25+ cells were 
enriched from single cell suspensions using biotinylated antibodies directed 
against  CD4  or  CD25,  respectively,  streptavidin-conjugated  microbeads, 
and the AutoMACS magnetic separation system (Miltenyi Biotec). Samples 
were analyzed on an LSRII or FACSCalibur or sorted using a FACSAria 
(BD). Data were analyzed using FlowJo software (Tree Star, Inc.).
T cell proliferation measurement. Where indicated, CD4+ T cells were 
labeled with 50 µM Pacific Blue succinimidyl ester or 1 or 10 µM CFSE 
(Invitrogen) for in vitro and in vivo proliferation measurements, respec-
tively, by incubation for 10 min at 37°C in the dark at a density of 106 cells/ml 
in PBS containing 0.1% BSA.
Adoptive  cell  transfer.  Indicated  FACS-purified,  Thy1.2,  or  CD45.1 
T cell populations were injected into lateral tail veins of Thy1.1 BALB/c or 
CD45.2  C57BL/6  congenic  recipient  mice,  respectively.  For  some   
involution, whereas T reg cell differentiation from peripheral 
precursors from the same mice appeared to remain more stable. 
Thus, peripheral T reg cell generation may be particularly 
important in settings of reduced thymic T reg cell produc-
tion. Interestingly, our preliminary experiments using BAC 
transgenic mice expressing a diphtheria toxin (DT) receptor–
GFP fusion protein under the control of the foxp3 gene locus 
(Lahl et al., 2007) indicated that DT administration to reduce 
T reg cell numbers resulted in a rapid increase of peripheral 
CD4+CD25+Foxp3 precursors and peripheral CD25+Foxp3+ 
T reg cell generation (unpublished data). This raises the pos-
sibility that thymic and peripheral T reg cell generation are 
linked by yet-to-be-defined feedback circuits to control pe-
ripheral T reg cell homeostasis.
Previous studies concerned with modalities of efficient   
DC-targeted peripheral T reg cell conversion from TCR 
transgenic CD4+ T cells established an inverse relationship of 
cell division and induced Foxp3 expression (Thorstenson and 
Khoruts, 2001; Kretschmer et al., 2005). This link between 
proliferation and conversion was supported by the notion 
that conditions that limit proliferation (low Ag dose, im-
mature DC maturation stage, reduced IL-2R, and enhanced 
TGF-R signaling) of converting cells increased Foxp3 up-
regulation and acquisition of a T reg cell phenotype. This in-
terpretation was recently corroborated in studies by Josefowicz 
et al. (2009) using DNA methyltransferase 1–deficient T cells, 
which revealed that one function of TGF- in T reg cell 
generation is to facilitate Foxp3 induction by opposing cell 
cycle–dependent Dnmt1-mediated silencing of the gene   
locus encoding Foxp3. Consistently, we have shown in this 
paper  that  IL-2R  signaling-dependent  up-regulation  of 
Foxp3 in initially CD4+CD25+Foxp3 polyclonal T reg pre-
cursor cells did not require proliferation and was abrogated 
by augmented TCR signaling. With regard to a function of 
TGF- in addition to cell cycle regulation, the present study 
suggested that TGF-R signaling in vivo plays a minor role 
in both generation and differentiation progression of extra-
thymic CD4+CD25+Foxp3 T reg precursor cells. Comple-
mentary  in  vitro  experiments  showed  that  abrogated  or 
enhanced TGF-R signaling had limited if any impact on 
Foxp3+ cell numbers from CD4+CD25+Foxp3 T reg pre-
cursor cell differentiation cultures. Thus, reminiscent of   
intrathymic T reg cell generation (Lio and Hsieh, 2008),   
extrathymic T reg cell generation from polyclonal precursor 
populations  can  proceed  by  TGF-–independent  mecha-
nisms. However, pharmacological abrogation of TGF-R sig-
naling resulted in somewhat reduced Foxp3 expression levels, 
which is consistent with the notion that TGF- enhances 
Foxp3 expression (Marie et al., 2005), perhaps by promoting 
Smad3 and NFAT binding to a Foxp3 enhancer region to 
support Foxp3 promoter activity (Tone et al., 2008).
With regard to cytokines involved in the reciprocal devel-
opmental pathways of Th17 and T reg cell generation, our ex-
periments provided evidence that abrogation of systemic IL-6 
levels, either by neutralizing anti–IL-6 mAbs or using gene-
targeted mice, did not lead to enhanced accumulation of pe-1406 Peripheral precursor to Foxp3+ T reg cells | Schallenberg et al.
Online supplemental material. Fig. S1 shows the phenotype of adop-
tively  transferred  TCR  transgenic  CD4+  T cells  in  untreated  recipients. 
Fig. S2 depicts the IL-2–dependent differentiation capacity of CD4+Foxp3 
T reg precursor cells with low or high CD25 expression and the effects of 
TCR stimulation, common gamma chain cytokines, and mTOR inhibition 
on precursor differentiation. Fig. S3 shows the biological activity of rapa-
mycin. Fig. S4 provides additional information on the impact of TGF-R 
signaling on T reg precursor cell differentiation. Fig. S5 depicts the role of 
IL-6 in T reg cell differentiation. Online supplemental material is available at 
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